[1] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324-329.
|
[2]Nyhan WL, Ozand PT.Atlas of metabolic diseases[M].London:Chapman HillMedical, 1998∶167-187.
|
[3]Sherlock S, Dosley J.Diseases of the liver and biliary system[M].Oxford:Blackwell Sci, 2002∶26-35.
|
[4]张丽华, 崇雨田, 庄鹏, 等.血氨对亚临床肝性脑病的影响[J].实用医学杂志, 2003, 19 (4) ∶376-377.
|
[5]王伙金, 郭为华.血氨测定前的影响因素探讨[J].福建医学杂志, 2001, 23 (5) ∶149.
|
[6]余久如, 杨浏.血氨酶法测定的影响因素[J].中华医学丛刊, 2004, 4 (7) ∶78.
|
[7]姚光弼.临床肝脏病学[M].上海:上海科学技术出版社, 2004∶38-40.
|
[1] | Xuhong YANG, Yong YANG, Minglei WANG, Wenxiao LIU, Wanlong MA, Minxing WANG, Xiangchun DING, Xiaodong WANG. Value of blood ammonia and cholinesterase in the early diagnosis of liver cirrhosis with minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2023, 39(2): 339-344. doi: 10.3969/j.issn.1001-5256.2023.02.013 |
[2] | Liang ZHANG, Hao LI, Shanhong TANG. Thoughts on the diagnosis and treatment of hepatic encephalopathy associated with blood ammonia in liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2942-2945. doi: 10.3969/j.issn.1001-5256.2023.12.028 |
[3] | Siqin LIU, Xiaomei WANG, Xia LI, Luwen LIANG, Ke WANG, Rui WANG. Covert hepatic encephalopathy in liver cirrhosis: Risk factors and prognosis[J]. Journal of Clinical Hepatology, 2022, 38(2): 359-364. doi: 10.3969/j.issn.1001-5256.2022.02.020 |
[4] | An GAO, Shu ZHANG, Jianhe GAN, Dong LI. Misdiagnosis of hepatic encephalopathy caused by hepatic telangiectasia: A case report[J]. Journal of Clinical Hepatology, 2021, 37(4): 916-917. doi: 10.3969/j.issn.1001-5256.2021.04.040 |
[5] | ZHANG QinFu, HAN HuanQin, ZHENG WeiQiang. Serum biomarkers for the early diagnosis of minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2020, 36(12): 2819-2821. doi: 10.3969/j.issn.1001-5256.2020.12.037 |
[6] | Tong JingJing, Mu XiuYing, Xu Xiang, Chen Jing, Zhai XingRan, Wang Yu, Su HaiBin, Liu XiaoYan, Hu JinHua. Association between blood ammonia and 90-day prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(6): 1304-1307. doi: 10.3969/j.issn.1001-5256.2019.06.024 |
[7] | Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022 |
[8] | Hu LiHua, Chen Peng, Wang XiaoLi, Zhang JiYe, Su LianMing, Zhang PeiYi. Relationship between zonula occludens-1 and blood-brain barrier permeability in rats with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2015, 31(4): 582-584. doi: 10.3969/j.issn.1001-5256.2015.04.025 |
[9] | Wang GuangChuan, Hu JinHua, Feng Hua, Tian XiangGuo, Shi YongJun, Zhang JunYong, Zhang ChunQing. Efficacy of percutaneous transhepatic variceal embolization with 2-Octyl-cyanoacrylate in patients with severe recurrent hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2013, 29(5): 365-369. |
[10] | Guo XiuLi, Zhao Hui, Liang PiXia, Xu YouQing. Clinical significance of the level of serum thyroxin in type - C HE patients[J]. Journal of Clinical Hepatology, 2011, 27(10): 1077-1080. |
[11] | Li YuYuan. Treatment of hepatic encephalopathy and minimal hepatic encephalopathy with L-ornitine-L-aspartate[J]. Journal of Clinical Hepatology, 2011, 27(1): 100-102. |
[12] | Xiang BaoYun, Song AiJun, Wang YuZhong. Clinical observation of ornithine aspartate combined with naloxone in the treatment of hepatic encephalopathy [J]. Journal of Clinical Hepatology, 2010, 26(1): 82-83. |
[16] | Yin HeKun, Li QiXiang, Luo Dan. The clinical study of L-ornithine-L-aspartate combined with SNMC for hepatic encephalopathy of liver cirrhosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 268-269. |
[18] | Wang Yu, Po YunFeng, Xu XianJi. A retrospective analysis of 74 patients with hipatic encephalopathy[J]. Journal of Clinical Hepatology, 2005, 21(3): 166-167. |
[19] | Sun YiFeng, Qin YongMei, Mao YongPing. Effects of anti-helicobacter pylori Therapy on the ammonia in patients with liver cirrhyosis[J]. Journal of Clinical Hepatology, 2001, 17(4): 237-238. |